MP5 Clozapine Prescribing and Monitoring Guideline


Category
Medicine management
Code
MP5
Issue No
6

Target Audience

All CWP staff

Purpose

The purpose of this guidance is to set out the standards for clinicians, pharmacy service providers, nursing staff and other health care professionals involved in the prescribing, administration and monitoring of clozapine. It covers initiation of clozapine (inpatient and community setting) and continuation of monitoring following initiation.

Origin

Lead executive
Medical Director

Author and contact number
Chief Pharmacist
01244 397379


Policy dates & history

Implementation Date

22 July 2017

Review Date

22 June 2022

Approval Meeting

Medicines Management Group


Appendices

Download

MP5 Clozapine Prescribing and Monitoring Guideline Issue 6.pdf

0.46MB
Download Now
Text size A- A+
Contrast options